DIFFICULTIES ENCOUNTERED BY TRANSGENDER MEN IN ACCESSING CERVICAL CYTOPATHOLOGICAL EXAMINATION IN PRIMARY HEALTH CARE: AN INTEGRATIVE REVIEW
DOI:
https://doi.org/10.56238/arev7n1-115Keywords:
Transgender People, Cervical Cancer, Pap Smear TestAbstract
Currently, the cytopathological exam is the main form of screening for cervical cancer and is offered free of charge by the Unified Health System. Despite identifying with the male gender, the transgender man may still have female reproductive organs, requiring this exam. The study aimed to assess the difficulties encountered by transgender men in accessing cytopathological examinations in Primary Health Care. This is an integrative literature review, which allows a broad approach to the topic, to seek relevant results that support the research. The research was conducted using the following databases: Medline, PubMed, and Scielo, using descriptors previously validated in the Health Sciences Descriptors (DeCS/MESH). The study allowed us to list the main difficulties of the trans population when undergoing cytopathological examinations, highlighting changes that must be made in care, to improve the quality of care and thus ensure the provision of continued care.
